Age (mean [SD]), years |
59.8 (12.7) |
60.1 (13.3) |
0.775 |
Hypertension, n (%) |
322 (65.4) |
165 (66) |
0.881 |
Diabetes, n (%) |
252 (51.2) |
133 (53.2) |
0.610 |
Hyperlipidemia, n (%) |
192 (39)
|
146 (58.6)
|
0.000
|
Valvular heart disease, n (%) |
20 (4.1)
|
32 (12.8)
|
0.000
|
Nonvalvular atrial fibrillation, n (%) |
23 (4.7) |
9 (3.6) |
0.496 |
Coronary artery disease, n (%) |
136 (27.6)
|
29 (11.6)
|
0.000
|
Tobacco smoking, n (%) |
146 (29.6)
|
0 (0.0)
|
0.000
|
Alcohol usage, n (%) |
149 (30.2)
|
0 (0.0)
|
0.000
|
Clinical presentation |
|
|
|
Weakness, n (%) |
372 (75.6) |
197 (78.8) |
0.331 |
Aphasia, n (%) |
121 (24.6) |
70 (28) |
0.316 |
Numbness, n (%) |
35 (7.1) |
18 (7.2) |
0.966 |
Blood sugar at admission, mean (±SD) |
161 (75.8) |
168 (73.5) |
0.180 |
HbA1C, mean (±SD) |
7.02 (1.68) |
7.27 (1.88) |
0.078 |
S. total cholesterol, mean (±SD) |
181 (52.2) |
196 (50.8) |
0.000
|
Stroke subtype |
|
|
|
Large artery atherosclerosis, n (%) |
105 (21.3)
|
37 (14.8)
|
0.032
|
Cardioembolic, n (%) |
97 (19.7)
|
68 (27.2)
|
0.020
|
Valvular heart disease, n (%) |
12 (12.4) |
32 (47)
|
0.0013
|
Nonvalvular atrial fibrillation, n (%) |
50 (51.5) |
23 (33.8)
|
0.024
|
Others |
35 (36.08)
|
23 (33.8)
|
0.92
|
Lacunar, n (%) |
102 (20.7) |
47 (18.8) |
0.535 |
Admission NIHSS, mean (SD) |
8.46 (6.62)
|
9.54 (6.91)
|
0.039
|
Time from onset to thrombolysis, mean (±SD), min |
194 (76.2) |
190 (85.0) |
0.755 |
Rate of thrombolysis, n (%) |
88 (17.8) |
42 (16.8) |
0.817 |
1. Intravenous |
64 (72.7) |
27 (64.3) |
0.326 |
2. Mechanical thrombectomy |
15 (17.0) |
9 (21.4) |
0.547 |
3. Bridging |
9 (10.3) |
6 (14.3) |
0.561 |
Symptomatic ICH after thrombolysis |
13 (14.7)
|
0 (0.0)
|
0.005
|
In-hospital mortality, n (%) |
16 (3.3) |
12 (4.8) |
0.296 |
mRS at 3 months, 1–2, n (%) |
326 (68.6)
|
148 (61.2)
|
0.046
|
Stroke recurrence at 3 months, n (%) |
14 (2.8) |
2 (0.8) |
0.070 |
3-month mortality, n (%) |
31 (6.5) |
21 (8.7) |
0.294 |